Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

Mitchell F. Brin, Cynthia L. Comella, Joseph Jankovic, Francis Lai, Markus Naumann, Fayyaz Ahmed, Allison Brashear, Mahan Chehrenama, Hanna Erjanti, Marian Evatt, Mark Forrest Gordon, David Grimes, Robert Hauser, Harald Hefter, Neil Hermanowicz, Matti Ilmavirta, Danna Jennings, Tapani Jolma, Petr Kaiňovský, Stefan KnechtJuan Carlos Martinez-Castrillo, Janice M. Massey, Eric Molho, Janis Miyasaki, Alex Rajput, Karlheinz Reiners, Evžen Ružčka, Axel Schramm, Lauren Seeberger, Scott Sherman, Thyagarajan Subramanian, Oksana Suchowersky, David Swope, Joseph Tsui, Miodrag Velickovic, Francis Walker

Research output: Contribution to journalArticlepeer-review

177 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay'. Together they form a unique fingerprint.

Medicine & Life Sciences